Low trypsin inhibitor soybean variety for feed and food use
This technology uses gene editing to turn down or turn off the genes in soybeans that produce trypsin inhibitors — natural compounds that interfere with protein digestion in animals and humans. Trypsin inhibitors are a longstanding nuisance in soy-based feed and food because they reduce the nutritional value of soy protein and require expensive heat-processing steps to neutralize. By engineering soybeans with reduced or eliminated trypsin inhibitor activity, the resulting grain could be more digestible, potentially safer for raw or minimally processed use, and more valuable as a protein source. The approach modifies specific KTI genes rather than adding foreign genes, which may offer a cleaner regulatory path than older GMO methods.
What you could build
A commercial soybean variety with low or no trypsin inhibitor activity, sold to seed companies or commodity grain buyers as a premium ingredient for animal feed, aquaculture feed, or minimally processed plant protein products — buyers include livestock feed formulators and alternative protein manufacturers.
Who in Virginia should care
Virginia's poultry and livestock feed industry, as well as soybean-growing operations in the Shenandoah Valley and Southside regions, would be natural early adopters or collaborators for field trials and commercialization.
Readiness: Concept
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Bo Zhang, Bingyu Zhao, Zhibo Wang
- Filed
- Patent pending — filed April 10, 2023
- Status
- Application
- Publication number
- US20230323375A1
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.